Search Results 711-720 of 16811 for Fibronolytic
The purpose of this study to assess pharmacodynamic (PD) changes in tumor tissue. Participation eligibility. Participant eligibility includes age, gender, type ...
About this study. The purpose of this study is to determine if elevations in oxidative stress, as measured by oxidation-reduction potential (ORP), ...
The purpose of this study is to gather information on the safety and effectiveness of cardiac resynchronization therapy (CRT) in patients who have mild heart ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, ...
Specifically, the primary objective is to evaluate if the incidence of anastomotic leak within 30 days is below the performance goal set at 9.3%. Participation ...
Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has ...
Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...
The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6-month PFS rate, ...
Learn about the expertise and advanced diagnostic and treatment services for people with complex or serious conditions of the heart and blood vessels.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.